U.S. Markets closed

PrestoDoctor's Rob Tankson Featured Guest at New York Fashion Week's FASHINNOVATIO

MESQUITE, NV / ACCESSWIRE / February 4, 2019/ Cannabis Sativa, Inc. (OTCQB: CBDS) is proud to announce that PrestoDoctor founder Rob Tankson will be a featured guest at FASHINNOVATION, a platform where fashion and technology connect with a mission to inspire and share knowledge in the fashion, entrepreneurship and technology sectors, is hosting the second edition of its semi-annual conference on February 13, 2019. The all-day red carpet event takes place during NYFW at one of the city's premiere venues, Tribeca Rooftop, and features panels, live performances, installations, displays, and aims to "humanize homelessness" with the launch of a book titled: It Can Be You by The NYLON Project.

FASHINNOVATION Conference will bring hundreds of industry innovators together on the final day of February's New York Fashion Week.

"The future is now, and as the tech and fashion industries converge, there's no better place to formalize conversations and networking opportunities by bringing these two industries together," says Jordana Guimaraes, co-founder of FASHINNOVATION.

"There's a reason why companies such as Farfetch and Revolve exist and are valued at billions of dollars - we need to pay attention to fashion tech innovation, and FASHINNOVATION is at this intersection," says Marcelo Guimaraes, founder of FASHINNOVATION.

FASHINNOVATION Second Edition expects approximately 500 guests and is presented by partner sponsors Runway Moda, ELYSIAIS, Lyft, and DisruptivAgency. The conference will showcase a fashion installation by Constanza+LAB (Spain) and 19-year-old IMI byImogen Evans, a mid-day cocktail hour and networking event, pop-up displays, a red carpet step-and-repeat, a special live performance by DeeMo, and an after-party by TROY. NYLON Project's book, It Can Be You, which includes 50 stories of homelessness from influencers around the world, including MelissaMolinaro, ClaudiaSalinas, Madeline Stuart, Eric Bigger, Thania Peck, Josh Heffler, and Jessica Ross, to name a few, will also be launched at the event and featured in a panel.

The first edition of FASHINNOVATION took place during NYFW on September 12, 2018, with hundreds of people exploring fashion tech panels from NASA, FIT, IBM, and more.

For more information, or to purchase tickets, go to https://fashinnovation.nyc/.


Ruben Ochoa Disruptiv Agency


We bridge the gap in conversation between the fashion and technology industries, inspiring an entrepreneurial mindset. Topics of discussion include design/creative, manufacturing/production, startup/ventures, e-commerce, sustainability and more. We build a diverse community of like-minded individuals in intersecting industries, keeping everyone abreast the latest in trends/innovations.

FASHINNOVATION was founded by husband/wife - Marcelo & Jordana Guimaraes - and originally put together as an idea that started in June 2018. During the planning and execution process, a simple email speaking of the concept sparked the attention of C levels of many organizations, including Samsung, Diane Von Furstenberg, Fergie, Louis Vuitton, Google, and CFDA. The launch event took place on September 12, 2018, this past NYFW.

About Presto Doctor:

PrestoDoctor ("Presto") https://prestodoctor.com offersthe greatest privacy and convenience while still offering fully qualified medical marijuana recommendations. Presto allows you to receive your medical marijuana recommendation from the comfort of your own home (currently, in California, Nevada and New York, and Pennsylvania only) - easy, fast, private. Presto is a member of the American Telemedicine Association and is HIPAA and HITECH compliant. Furthermore, Presto's doctors are licensed with the appropriate state medical boards and complete periodic marijuana training courses.

About Cannabis Sativa, Inc.:

Cannabis Sativa, Inc. (''CBDS'') is engaged in the licensing of cannabis related intellectual property, marketing and branding for cannabis based products and services, operation of cannabis related technology services, and ancillary business activities. CBDS licenses the ''hi'' and ''White Rabbit'' brands, holds a U.S. patent on the Ecuadorian Sativa strain of Cannabis, a U.S. Patent for a marijuana lozenge; a Cannabis-based pharmaceutical composition for the treatment of hypertensive disorders by submucosal delivery and trade secret formulas and processes, offers the hi benefits discount pharmacy card, and operates subsidiaries including: PrestoDoctor® (https://prestodoctor.com),Wild Earth Naturals®, (https://wildearthnaturals.com),and iBudtender (https//:ibudtender.com). The Company is the official licensee for Virgin Mary Jane Brand(https://virginmaryjanebrand.com) In addition, CBDS seeks strategic partners for acquisition of operating companies, intellectual property and other assets which fit within the CBDS corporate vision

Forward-Looking Statements:

This press release contains ''forward-looking statements.'' Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged to carefully review and consider the various disclosures made byus in our reports filed with the Securities and Exchange Commission, including the risk factors that attempt to advise interested parties of the risks that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Underlying assumptions include without limitation, the ongoing enactment of legislation favorable to the production of and the commercialization of cannabis products and the Company's success in capitalizing on that legislation. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.

Contact Information:

Investor Relations
1646 West Pioneer Blvd Suite 120
Mesquite, NV 89027

SOURCE: Cannabis Sativa, Inc.

View source version on accesswire.com: